Literature DB >> 10810961

Estrogen replacement therapy and gallbladder disease in postmenopausal women.

M L Uhler1, J W Marks, H L Judd.   

Abstract

OBJECTIVE: To examine the role of estrogen replacement therapy on the development of gallbladder disease in postmenopausal women.
DESIGN: Systematic review of the English literature was conducted. All studies that addressed the association between hormone replacement therapy and gallbladder disease published from 1970 to the present were reviewed.
RESULTS: Seven observational studies, two clinical trials, two case series, and one nonrandomized and three randomized investigations were reviewed. The results of each study were reported and analyzed.
CONCLUSIONS: Estrogen replacement therapy in postmenopausal women increased the chances for gallstone formation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10810961     DOI: 10.1097/00042192-200007030-00006

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  15 in total

1.  Postmenopausal estrogen therapy and risk of gallstone disease: a population-based case-control study.

Authors:  Maja Hellfritzsch Simonsen; Rune Erichsen; Trine Frøslev; Jørgen Rungby; Henrik Toft Sørensen
Journal:  Drug Saf       Date:  2013-12       Impact factor: 5.606

Review 2.  Gender and gallstone disease.

Authors:  Gottfried Novacek
Journal:  Wien Med Wochenschr       Date:  2006-10

Review 3.  Estradiol and norgestimate: a review of their combined use as hormone replacement therapy in postmenopausal women.

Authors:  M P Curran; A J Wagstaff
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

4.  Alterations in gallbladder emptying and bile retention in the absence of changes in bile lithogenicity in postmenopausal women on hormone replacement therapy.

Authors:  Radha K Dhiman; Pralay K Sarkar; Arpita Sharma; Kala Vasishta; Krishan K Kohli; Sanjay Gupta; Sudha Suri; Yogesh Chawla
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

5.  Reproductive factors and risks of biliary tract cancers and stones: a population-based study in Shanghai, China.

Authors:  G Andreotti; L Hou; Y-T Gao; L A Brinton; A Rashid; J Chen; M-C Shen; B-S Wang; T-Q Han; B-H Zhang; L C Sakoda; J F Fraumeni; A W Hsing
Journal:  Br J Cancer       Date:  2010-03-09       Impact factor: 7.640

6.  Menopausal hormone therapy and risk of cholecystectomy: a prospective study based on the French E3N cohort.

Authors:  Antoine Racine; Anne Bijon; Agnès Fournier; Sylvie Mesrine; Françoise Clavel-Chapelon; Franck Carbonnel; Marie-Christine Boutron-Ruault
Journal:  CMAJ       Date:  2013-03-18       Impact factor: 8.262

7.  Benefits and harms associated with hormone replacement therapy: clinical decision analysis.

Authors:  Cosetta Minelli; Keith R Abrams; Alex J Sutton; Nicola J Cooper
Journal:  BMJ       Date:  2004-02-14

Review 8.  New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation.

Authors:  Helen H Wang; Min Liu; Deborah J Clegg; Piero Portincasa; David Q-H Wang
Journal:  Biochim Biophys Acta       Date:  2009-07-06

9.  Variants in hormone-related genes and the risk of biliary tract cancers and stones: a population-based study in China.

Authors:  Sue K Park; Gabriella Andreotti; Lori C Sakoda; Yu-Tang Gao; Asif Rashid; Jinbo Chen; Bingshu E Chen; Philip S Rosenberg; Ming-Chang Shen; Bing-Sheng Wang; Tian-Quan Han; Bai-He Zhang; Meredith Yeager; Stephen Chanock; Ann W Hsing
Journal:  Carcinogenesis       Date:  2009-01-23       Impact factor: 4.944

10.  Molecular Mechanisms Underlying the Link between Nuclear Receptor Function and Cholesterol Gallstone Formation.

Authors:  Mary Carmen Vázquez; Attilio Rigotti; Silvana Zanlungo
Journal:  J Lipids       Date:  2011-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.